Strategic Global Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.95M | Sell |
17,715
-440
| -2% | -$282K | 1.59% | 16 |
|
|
2025
Q4 | $12.3M | Buy |
18,155
+280
| +2% | +$191K | 1.9% | 8 |
|
|
2025
Q3 | $11.4M | Sell |
17,875
-275
| -2% | -$167K | 1.73% | 14 |
|
|
2025
Q2 | $9.73M | Buy |
18,150
+8,623
| +91% | +$4.12M | 1.59% | 13 |
|
|
2025
Q1 | $4M | Sell |
9,527
-361
| -4% | -$157K | 0.79% | 42 |
|
|
2024
Q4 | $4.09M | Buy |
9,888
+384
| +4% | +$168K | 0.75% | 42 |
|
|
2024
Q3 | $4.8M | Sell |
9,504
-95
| -1% | -$46.2K | 0.95% | 35 |
|
|
2024
Q2 | $4.68M | Buy |
9,599
+182
| +2% | +$91.4K | 0.98% | 28 |
|
|
2024
Q1 | $5.08M | Buy |
9,417
+7,358
| +357% | +$4.02M | 1.1% | 31 |
|
|
2023
Q4 | $1.14M | Sell |
2,059
-1,393
| -40% | -$654K | 0.26% | 102 |
|
|
2023
Q3 | $1.51M | Buy |
+3,452
| New | +$1.72M | 0.25% | 106 |
|
|
2022
Q3 | – | Sell |
-19,112
| Closed | -$6.7M | – | 148 |
|
|
2022
Q2 | $6.7M | Buy |
19,112
+2,090
| +12% | +$852K | 1.02% | 34 |
|
|
2022
Q1 | $9.31M | Buy |
17,022
+835
| +5% | +$439K | 1.36% | 23 |
|
|
2021
Q4 | $10.7M | Buy |
16,187
+1,334
| +9% | +$837K | 1.38% | 16 |
|
|
2021
Q3 | $9.24M | Buy |
14,853
+3,510
| +31% | +$2.36M | 1.35% | 18 |
|
|
2021
Q2 | $7.16M | Sell |
11,343
-1,542
| -12% | -$851K | 1.3% | 15 |
|
|
2021
Q1 | $6.3M | Buy |
12,885
+238
| +2% | +$119K | 1.14% | 21 |
|
|
2020
Q4 | $6.32M | Sell |
12,647
-1,305
| -9% | -$584K | 1.12% | 22 |
|
|
2020
Q3 | $5.49M | Buy |
13,952
+72
| +0.5% | +$26.6K | 1.03% | 32 |
|
|
2020
Q2 | $4.58M | Buy |
13,880
+1,952
| +16% | +$565K | 0.98% | 30 |
|
|
2020
Q1 | $2.89M | Buy |
11,928
+360
| +3% | +$94K | 0.74% | 40 |
|
|
2019
Q4 | $3.02M | Sell |
11,568
-848
| -7% | -$223K | 0.63% | 47 |
|
|
2019
Q3 | $3.38M | Sell |
12,416
-930
| -7% | -$259K | 0.76% | 40 |
|
|
2019
Q2 | $3.67M | Sell |
13,346
-182
| -1% | -$44.8K | 0.78% | 35 |
|
|
2019
Q1 | $3.02M | Buy |
13,528
+4,992
| +58% | +$1.03M | 0.64% | 49 |
|
|
2018
Q4 | $1.59M | Sell |
8,536
-1,630
| -16% | -$334K | 0.57% | 34 |
|
|
2018
Q3 | $2.54M | Sell |
10,166
-27
| -0.3% | -$6.55K | 0.77% | 30 |
|
|
2018
Q2 | $1.95M | Hold |
10,193
| – | – | 0.5% | 46 |
|
|
2018
Q1 | $1.95M | Hold |
10,193
| – | – | 0.67% | 36 |
|
|
2017
Q4 | $1.59M | Sell |
10,193
-280
| -3% | -$44.1K | 0.52% | 48 |
|
|
2017
Q3 | $1.63M | Hold |
10,473
| – | – | 0.62% | 47 |
|
|
2017
Q2 | $1.69M | Sell |
10,473
-2,020
| -16% | -$328K | 0.62% | 40 |
|
|
2017
Q1 | $1.93M | Sell |
12,493
-733
| -6% | -$101K | 0.7% | 42 |
|
|
2016
Q4 | $1.55M | Buy |
+13,226
| New | +$1.51M | 0.58% | 52 |
|
Other funds holding IDXX
VCM
VPM
Strategic Global Advisors's IDXX Position: Q1 2026 in Review
Strategic Global Advisors reduced its Idexx Laboratories (IDXX) stake by 2.4% in Q1 2026, selling an estimated $282K and leaving 17,715 shares worth $9.95M. The position accounts for 1.59% of the portfolio, ranked #16.
Strategic Global Advisors first reported a position in IDXX in Q4 2016 and has held it in 34 quarters since. The position peaked at $12.3M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Strategic Global Advisors held 17,715 shares of Idexx Laboratories worth $9.95M as of Q1 2026.
- Strategic Global Advisors sold 440 Idexx Laboratories shares in Q1 2026, an estimated $282K.
- Idexx Laboratories made up 1.59% of Strategic Global Advisors's portfolio in Q1 2026, its #16 holding.
- Strategic Global Advisors first reported a position in Idexx Laboratories in Q4 2016 and has held it in 34 quarters since.
- Strategic Global Advisors's Idexx Laboratories position peaked at $12.3M in Q4 2025.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Strategic Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.